ArticleJournal of assisted reproduction and genetics2026
Evaluating the time interval between oocyte retrieval and micro testicular sperm extraction: a single-center retrospective cohort study.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the embryological and clinical outcomes of couples undergoing micro testicular sperm extraction (TESE) at 24 h or 48 h before oocyte retrieval and intracytoplasmic sperm injection (ICSI).
methodsWe conducted a retrospective study of 129 ICSI cycles using sperm recovered by micro-TESE from a single fertility center between June 2015 and January 2025. Patients were stratified according to timing of oocyte retrieval following micro-TESE: 24 h (n = 104) vs. 48 h (n = 25). Baseline demographics, including age, hormonal profile, and degree of sperm concentration (non-obstructive azoospermia, cryptozoospermia, or severe oligoasthenoteratozoospermia), were collected. Embryological outcomes included the number of retrieved oocytes, mature oocytes (MII), fertilization rate, and blastocyst formation (2PN). Clinical outcomes assessed were biochemical pregnancy, clinical pregnancy, and live birth rates.
resultsBaseline characteristics did not differ significantly between groups. Of note, given the retrospective nature of the study, we could not control for factors such as oocyte quality, protocol variations, and reasons for a delayed cycle. Embryological outcomes, including fertilization rate (67% vs. 65%; p = 0.81) and blastocyst rate (50% ± 26 vs. 49% ± 29; p = 0.90), were comparable between the 24-h and 48-h groups. However, significant differences were observed in clinical outcomes: positive β-hCG rates were higher in the 24-h group (72% vs. 35%; p = 0.002)), as were clinical pregnancy rates (65% vs. 35%; p = 0.01) and live birth rates (56% vs. 30%; p = 0.03).
conclusionAlthough prior studies have shown that sperm culture up to 48 h may enhance motility, the current study demonstrates that an extended culture may be associated with less favorable clinical outcomes. Our findings demonstrate that oocyte retrieval within 24 h of micro-TESE was associated with higher clinical pregnancy and live birth rates compared to longer culture intervals. Given the retrospective design, these findings should be interpreted cautiously, and prospective randomized studies are needed to better define the optimal timing between micro-TESE and oocyte retrieval.
Indexed as
Identifiers
42850542What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.